Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

Karasik, A (author)

Lanzinger, S (author)

Chia-Hui Tan, E (author)

show more...

Yabe, D (author)

Kim, DJ (author)

Sheu, WH (author)

Melzer-Cohen, C (author)

Holl, RW (author)

Ha, KH (author)

Khunti, K (author)

Zaccardi, F (author)

Subramanian, A (author)

Nirantharakumar, K (author)

Nyström, T (author)

Karolinska Institutet

Niskanen, L (author)

Linnemann Jensen, M (author)

Hoti, F (author)

Klement, R (author)

Déruaz-Luyet, A (author)

Kyaw, MH (author)

Koeneman, L (author)

Vistisen, D (author)

Carstensen, B (author)

Halvorsen, S (author)

Langslet, G (author)

Fazeli Farsani, S (author)

Patorno, E (author)

Núñez, J (author)

show less...

 (creator_code:org_t)

2023

2023

English.

In: Diabetes & metabolism. - 1878-1780. ; 49:2, s. 101418-

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)